Phoenix and Raven Become First Canadian Telehealth Platforms to Offer Generic Semaglutide Direct to Patients
· Financial Post
TORONTO -- Today, Phoenix and Raven, leading Canadian digital health providers, announced the launch of generic semaglutide for direct-to-patient access in Canada, making them the first telehealth platform in the country to bring this medication to customers. Phoenix and Raven are looking to set the new pricing for optimal access with orders starting at $124.99, delivered by prescription across Canada. Read More
Visit rouesnews.click for more information.